President Trump could have walked softly and carried a big stick. As pharmaceutical investors see it, he instead stomped ...

The lines between fact, science, and uncertainty are increasingly blurred. Things once treated as dogma are being questioned.

Biotech investment firm RA Capital has laid off staff at its internal startup incubator, highlighting the instability among ...

Our most dangerous epidemic right now is not Covid, it is obesity, and we have the basic tools to fight it. Means is a ...

The emergence of Haemanthus, a company formed by Elizabeth Holmes’ partner, Billy Evans, triggered a mix of shock, anger, and ...

Trump's executive order lacks specifics and raises questions on what can be accomplished, what will be challenged in court.

President Trump unveiled his plan to dramatically overhaul the way the U.S. pays for drugs. Pharma investors didn't seem to ...

House Republicans have unveiled their plan to reshape Medicaid, looking for cost savings as a way to offset planned tax cuts.

The White House unveiled a sweeping plan to try to lower prescription drug prices, one that calls for a "most-favored nation" ...

Meanwhile, health secretary Robert F. Kennedy Jr. and his lieutenants have sent multiple signals in recent weeks that they ...

Chinese and Chinese-American researchers are reassessing their futures in the U.S., potentially shifting the balance in ...

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...